Life sciences stories
The GxP version adds validation and audit trails for drug and device makers that need cloud monitoring without a local application server.
The setup should ease cell therapy scale-up by giving developers industrial-grade control and more reproducible data before GMP production.
Businesses can now trial quantum workloads in London as the room-temperature system is already being used for protein design and energy scheduling.
The upgrade is meant to help more than 40 healthcare clients handle rising order volumes while meeting strict pharmaceutical compliance demands.
The funding will help the Chicago-based company build a new headquarters and biomanufacturing site as it targets growers facing tighter margins.
The four-year effort, backed by €6.5 million from Horizon Europe, aims to speed vaccine design for emerging infectious diseases and future pandemics.
The trial could help doctors spot eligible patients sooner and bring research findings into routine care, improving evidence generation.
Researchers and startups could gain easier access to AI tools, training and European computing power as the Commission teams up with Nvidia.
Only 5.2% of organisations in Australia and New Zealand have scaled AI beyond pilots, with structure and workflows proving the biggest barriers.
Keeping customer and transaction data in-house, the software aims to cut the need for copied databases as firms train AI models.
Most life sciences manufacturers now see digital transformation as essential, with 54% reporting a cyberattack in the past year and many eyeing AI.
The construction consultancy's next phase of growth will be led by an internal appointee as it expands across 44 offices in 30 countries.
Europe's enterprise AI debate will centre on data sovereignty and governance as banks, drugmakers and universities gather in London.
Many security chiefs expect to curb AI agent use within 18 months as fears grow over unauthorised access and weak audit trails.
Only one in 10 senior executives are very confident they can add capacity fast enough, as bottlenecks threaten growth in four key sectors.
The funding will help Tamr speed up development of agentic features as enterprises struggle to make fragmented records usable for AI systems.
Weaker bookings weighed on Wipro's outlook even as the IT outsourcer lifted margins and generated ₹53.0 billion in operating cash flow.
Despite rapid adoption, UK firms are struggling to turn AI spending into measurable gains, with trust and returns still out of sync.
The expansion gives the group a bigger base to serve Southeast Asian customers and train talent as manufacturers step up research in Singapore.
Britain's life sciences start-ups could get a lift as the British Business Bank injects GBP £135 million into two Advent funds.